Discovery and Optimization of Novel Antagonists to the Human Neurokinin‑3 Receptor for the Treatment of Sex-Hormone Disorders (Part I)
Hoveyda, Hamid R, Fraser, Graeme L, Roy, Marie-Odile, Dutheuil, Guillaume, Batt, Frédéric, El Bousmaqui, Mohamed, Korac, Julien, Lenoir, François, Lapin, Alexey, Noël, Sophie, Blanc, Sébastien
Published in Journal of medicinal chemistry (09.04.2015)
Published in Journal of medicinal chemistry (09.04.2015)
Get full text
Journal Article
Annexin-I expression modulates drug resistance in tumor cells
Wang, Ying, Serfass, Lucile, Roy, Marie-Odile, Wong, Judy, Bonneau, Anne-Marie, Georges, Elias
Published in Biochemical and biophysical research communications (06.02.2004)
Published in Biochemical and biophysical research communications (06.02.2004)
Get full text
Journal Article
Protein interactions in concentrated ribonuclease solutions
Boyer, Mireille, Roy, Marie-Odile, Jullien, Magali, Bonneté, Françoise, Tardieu, Annette
Published in Journal of crystal growth (01.01.1999)
Published in Journal of crystal growth (01.01.1999)
Get full text
Journal Article
Conference Proceeding
NK-3 N--5678---[124][43-a] NK-3 NOVEL CHIRAL N-ACYL-5678-SUBSTITUTED-TETRAHYDRO-[124]TRIAZOLO[43-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS PHARMACEUTICAL COMPOSITION METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
DUTHEUIL GUILLAUME, ROY MARIE ODILE, FRASER GRAEME, EL BOUSMAQUI MOHAMED, BATT FREDERIC, HOVEYDA HAMID
Year of Publication 28.11.2019
Get full text
Year of Publication 28.11.2019
Patent
Does fusion of domains from unrelated proteins affect their folding pathways and the structural changes involved in their function? A case study with the diphtheria toxin T domain
Chenal, Alexandre, Nizard, Philippe, Forge, Vincent, Pugnière, Martine, Roy, Marie-Odile, Mani, Jean-Claude, Guillain, Florent, Gillet, Daniel
Published in Protein engineering (01.05.2002)
Published in Protein engineering (01.05.2002)
Get full text
Journal Article
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
DUTHEUIL GUILLAUME, ROY MARIE ODILE, FRASER GRAEME, EL BOUSMAQUI MOHAMED, BATT FREDERIC, HOVEYDA HAMID
Year of Publication 13.06.2014
Get full text
Year of Publication 13.06.2014
Patent
Corrigendum to “Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor” [Bioorg. Med. Chem. Lett. 21 (2011) 1991–1996]
Hoveyda, Hamid R., Roy, Marie-Odile, Blanc, Sebastien, Noël, Sophie, Salvino, Joseph M., Ator, Mark A., Fraser, Graeme
Published in Bioorganic & medicinal chemistry letters (01.12.2011)
Published in Bioorganic & medicinal chemistry letters (01.12.2011)
Get full text
Journal Article
Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK sub(3 receptor)
Hoveyda, Hamid R, Roy, Marie-Odile, Blanc, Sebastien, Noel, Sophie, Salvino, Joseph M, Ator, Mark A, Fraser, Graeme
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Get full text
Journal Article
Corrigendum to “Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK 3 receptor” [Bioorg. Med. Chem. Lett. 21 (2011) 1991–1996]
Hoveyda, Hamid R., Roy, Marie-Odile, Blanc, Sebastien, Noël, Sophie, Salvino, Joseph M., Ator, Mark A., Fraser, Graeme
Published in Bioorganic & medicinal chemistry letters (2011)
Published in Bioorganic & medicinal chemistry letters (2011)
Get full text
Journal Article
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
Roy, Marie-Odile, El Bousmaqui, Mohamed, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume
Year of Publication 09.03.2021
Get full text
Year of Publication 09.03.2021
Patent
NOVEL CHIRAL N-ACYL-5,6,7(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
Roy, Marie-Odile, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume, Bousmaqui, Mohamed El
Year of Publication 10.09.2020
Get full text
Year of Publication 10.09.2020
Patent
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
Roy, Marie-Odile, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume, Bousmaqui, Mohamed El
Year of Publication 16.06.2020
Get full text
Year of Publication 16.06.2020
Patent